We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patient Data Can Bolster Evidence of Drug Benefits
Patient Data Can Bolster Evidence of Drug Benefits
February 10, 2006
Patient-reported outcome (PRO) data can provide evidence of a treatment benefit from the patient perspective, bolstering manufacturer’s claims about a drug’s benefit, according to FDA draft guidance.